1-year ‘satisfactory’ application of insurance benefit for Daklinza for treatment of hepatitis C
After the mass hepatitis C infection incident, the Korea Centers for Disease Control and Prevention(KCDC) recently revealed the reaction of Korean hepatitis C patients to interferon and the effect of treatment after adopting DAAs(direct-acting antivirals) in the ‘Status and Measure for Hepatitis ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
